NYCTEA TECHNOLOGIES
Nyctea Technologies creates purification and administration of Biopharmaceuticals using electronically activated biomolecule control.
NYCTEA TECHNOLOGIES
Social Links:
Industry:
Biotechnology
Founded:
2020-01-01
Address:
Gรถteborg, Vastra Gotaland, Sweden
Country:
Sweden
Website Url:
http://www.nycteatechnologies.com
Total Employee:
1+
Status:
Active
Total Funding:
5.65 K USD
Technology used in webpage:
Viewport Meta Google Font API Google Maps Mobile Optimized One.com Website Builder
Current Employees Featured
Founder
Investors List
Chalmers Ventures AB
Chalmers Ventures AB investment in Pre Seed Round - Nyctea Technologies
Official Site Inspections
http://www.nycteatechnologies.com
- Host name: webcluster1.webpod12-cph3.one.com
- IP address: 46.30.213.23
- Location: Copenhagen Denmark
- Latitude: 55.6786
- Longitude: 12.5589
- Timezone: Europe/Copenhagen
- Postal: 1052
More informations about "Nyctea Technologies"
Nyctea Technologies
Providing unique and unparalleled electronic control over purification of next gen biopharmaceuticalsSee details»
About - Nyctea Technologies
Nyctea Technologies was founded in 2020 by Gustav Ferrand-Drake del Castillo and professor Andreas Dahlin at Chalmers University of Technology in Sweden. Their research was initially focused on fundamental science, aimed to improve โฆSee details»
Nyctea Technologies - LinkedIn
Nyctea Technologies creates affordable medicine by introducing a new purification technology removing a bottleneck in the manufacturing process that drastically reduces the cost-of-goods.See details»
Technology | Nyctea Technologies
Creating an alternative to chromatography separation, lowering the price of biopharmaceutical production. Creating a new opportunities for implantable drug delivery and microdosing. โฆSee details»
Nyctea Technologies - Crunchbase Company Profile & Funding
Nyctea Technologies creates purification and administration of Biopharmaceuticals using electronically activated biomolecule control. View contacts for Nyctea Technologies to access โฆSee details»
Nyctea Technologies Company Profile 2024: Valuation, โฆ
Developer of a purification technology company designed for biopharmaceutical and protein production. The company's technology manufactures biomolecule purification systems for discovering the biomolecule trapping functionalities of โฆSee details»
Nyctea Technologies - Gรถteborg, Sweden - bionity.com
Jun 22, 2022ย ยท Our mission is to lower the cost and increase the speed of production of biological pharmaceuticals and to accelerate the development of the next generation of medical โฆSee details»
Nyctea Technologies - Chalmers Ventures
The purpose of Nyctea Technologies is to increase the efficiency in the production of biological pharmaceuticals. Antibodies, gene vectors and vaccines are effective treatments against a โฆSee details»
Nyctea Technologies - EU-Startups
Nyctea Technologies was founded in 2020 by PhD student Gustav Ferrand-Drake del Castillo and his supervisor professor Andreas Dahlin at Chalmers University of Technology. Their research was initially focused on fundamental science โฆSee details»
Nyctea Technologies | VentureRadar
Website: https://www.nycteatechnologies.com/ Develops innovative methods for controlling interactions between polyelectrolyte brushes and biomolecules, aiming to reduce costs and โฆSee details»
News | Nyctea Technologies
Nyctea Technologies has been recognized on IVA's prestigious 100 List of Swedish Innovations! ?. Being featured on IVA's 100 List is a testament to Nyctea's innovative spirit and dedication to โฆSee details»
Nyctea Technologies Overview | SignalHire Company Profile
Nyctea Technologies creates purification and administration of Biopharmaceuticals using electronically activated biomolecule control.See details»
Nyctea Technologies โ Funding, Valuation, Investors, News
Http://www.nycteatechnologies.com/ Tags: Analytics BioTech Development Diagnostics Industry Life Manufacturing Pharmacy Production We are providing electronically activated purification โฆSee details»
Nyctea Technologies - VentureRadar
Website: https://www.nycteatechnologies.com/ Nyctea Technologies was founded in 2020 by PhD student Gustav Ferrand-Drake del Castillo and his supervisor professor Andreas Dahlin at โฆSee details»
Nyctea Technologies - VentureRadar
Website: https://www.nycteatechnologies.com/ Develops innovative methods for controlling interactions between polyelectrolyte brushes and biomolecules, aiming to reduce costs and โฆSee details»
Nycteatechnologies - Company Profile - Tracxn
Oct 25, 2024ย ยท Nycteatechnologies ranks 94th among 94 competitors. 8 of its competitors are funded while 13 have exited. Overall, Nycteatechnologies and its competitors have raised over โฆSee details»
News AstraZeneca Collaboration | Nyctea Technologies
Mรถlndal, Sweden, 31-jan-2024. Nyctea Technologies Enters Research Collaboration with AstraZeneca to Enhance Biopharmaceutical Purification . The collaboration leverages โฆSee details»
Nyctea Technologies - Products, Competitors, Financials, โฆ
Nyctea Technologies specializes in the biopharmaceutical sector with a focus on innovating the purification process of biopharmaceuticals. The company offers a technology that enables โฆSee details»
Publications - Nyctea Technologies
Ferrand-Drake et al. Electrically Switchable Polymer Brushes for Protein Capture and Release in Biological Environments. Angew. Chem. Int. Ed. 2022, 61, e202115745 Ferrand-Drake et al. โฆSee details»
Nyctea Competes as Finalist in the BioTools Innovator Capstone โฆ
Nyctea Technologies competed in the BioTools Innovator Capstone final! Out of +400 applicants we made it to the top 4! The competition in the final was fierce with Redbud Labs, Syenex and โฆSee details»